Posted on 03/11/2009 8:05:26 PM PDT by grey_whiskers
Home Business & Finance News U.S. Politics International Technology Entertainment Sports Lifestyle Oddly Enough Environment Health Science Special Coverage Video Pictures Your View The Great Debate Blogs Weather Reader Feedback Do More With Reuters RSSRSS Feed Widgets Mobile Podcasts Newsletters Your View Make Reuters My Homepage Partner Services CareerBuilder Affiliate Network Professional Products Support (Customer Zone) Reuters Media Financial Products About Thomson Reuters Experts use nanotech to deliver anti-cancer genes Tue Mar 10, 2009 12:31pm EDT
Email | Print | Share | Reprints | Single Page [-] Text [+]
LONDON (Reuters) - British scientists said on Tuesday they had developed a treatment that transports anti-cancer genes selectively into cancer cells using nanotechnology.
The therapy has so far only been tried out on mice, but the aim is to test it in humans within two years.
If it works in people, it would provide a highly targeted mechanism for delivering cancer-fighting gene therapy.
Cancer Research UK's Andreas Schatzlein, based at the School of Pharmacy in London, said it was the first time that nanoparticles had been shown to target tumors in such a selective way.
(Excerpt) Read more at reuters.com ...
Wow
Anything that replaces the miserable chemo is most welcome.
Star Trek, here we come!!!!
Thank God it’s the experts doing this!
The idea is to free gene implantation from having to use viruses.
That said, I still think Morgellons is some kind of self-replicating nanotechnology gone berserk.
It’s just amazing to think that Obama had time to develop this when he’s so busy saving the economy(!)
Cheers!
Sorry, I was just goofing.
But seriously, I could see Michael Crichton taking that ball and running with it.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.